Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Global and Sex-Stratified Genome-Wide Association Study of Long COVID Based on Patient-Driven Symptom Recall

  • Polo-Alonso, Sara
  • Hernáez, Álvaro|||0000-0001-8593-1477
  • Degano, Irene R.|||0000-0003-1914-6934
  • Martí-Lluch, Ruth|||0000-0002-7320-9521
  • Pinsach-Abuin, Mel Lina
  • Elosua, Roberto|||0000-0001-8235-0095
  • Subirana, Isaac|||0000-0003-1676-0197
  • Puigmulé, Marta
  • Pérez, Alexandra|||0000-0001-5344-6573
  • Cruz, Raquel|||0000-0002-6964-8898
  • Diz-de Almeida, Silvia|||0000-0003-2813-8928
  • Puigdecant, Eulàlia
  • Selga, Elisabet|||0000-0002-4290-8370
  • Nogués Solán, Xavier|||0000-0002-5537-1859
  • Masclans, Joan R.|||0000-0002-0809-6823
  • Güerri-Fernández, Robert|||0000-0002-9794-9161
  • Cubero-Gallego, Hector|||0000-0001-9740-827X
  • Tizón-Marcos, Helena|||0000-0001-7942-9413
  • Vaquerizo, Beatriz|||0000-0002-1428-3596
  • Brugada, Ramon|||0000-0001-6607-3032
  • Ramos, Rafel|||0000-0001-7970-5537
  • Camps-Vilaró, Anna|||0000-0001-9644-8421
  • Marrugat, Jaume|||0000-0003-3320-554X
We aimed to explore the global and sex-specific genetic variants associated with long COVID, as defined by patient-driven symptom recall. A 1-year cohort study of 2411 COVID-19 patients collected long COVID symptoms with an open-ended, non-directed questionnaire, and long COVID incidence was determined according to the World Health Organization definition. Global and sex-stratified genome-wide association analyses were conducted by logistic regression models adjusted for age, sex (in the global analysis), and the first 10 principal components. We assessed sex-variant interactions and performed gene-based analyses, gene mapping, and gene-set enrichment analyses. When comparing the 1392 long COVID cases with the non-cases, we identified 23 lead variants from suggestive signals: 13 from the global analysis, 5 from females, and 5 from males. Five variants showed a significant interaction with sex (two in females, three in males). We mapped 15 protein-coding genes related to diseases of the immune and nervous systems and tumoral processes. Notably, CD5 and VPS37C, linked to immune function, were significantly associated with long COVID in men. Our results suggest that persistent immune dysregulation may be involved in the development of precisely defined long COVID.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Association of circulating microRNAs with coronary artery disease and usefulness for reclassification of healthy individuals, The REGICOR study

  • Degano, Irene R.|||0000-0003-1914-6934
  • Camps-Vilaró, Anna|||0000-0001-9644-8421
  • Subirana, Isaac|||0000-0003-1676-0197
  • García-Mateo, Nadia
  • Cidad, Pilar
  • Muñoz Aguayo, Daniel|||0000-0001-8173-0168
  • Puigdecanet, Eulàlia|||0000-0001-6067-9332
  • Nonell, Lara|||0000-0002-8538-8213
  • Vila-Domènech, Joan Salvador|||0000-0002-0413-9291
  • Crepaldi, Felipe Mingorance|||0000-0002-8500-1162
  • Gonzalo Calvo, David de|||0000-0003-2240-3532
  • Llorente-Cortés, Vicenta|||0000-0002-0067-7201
  • Pérez-García, María Teresa|||0000-0001-8540-8117
  • Elosua, Roberto|||0000-0001-8235-0095
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Marrugat, Jaume|||0000-0003-3320-554X
Risk prediction tools cannot identify most individuals at high coronary artery disease (CAD) risk. Oxidized low-density lipoproteins (oxLDLs) and microRNAs are actively involved in atherosclerosis. Our aim was to examine the association of CAD and oxLDLs-induced microRNAs, and to assess the microRNAs predictive capacity of future CAD events. Human endothelial and vascular smooth muscle cells were treated with oxidized/native low-density lipoproteins, and microRNA expression was analyzed. Differentially expressed and CAD-related miRNAs were examined in serum samples from (1) a case-control study with 476 myocardial infarction (MI) patients and 487 controls, and (2) a case-cohort study with 105 incident CAD cases and 455 randomly-selected cohort participants. MicroRNA expression was analyzed with custom OpenArray plates, log rank tests and Cox regression models. Twenty-one microRNAs, two previously undescribed (hsa-miR-193b-5p and hsa-miR-1229-5p), were up- or down-regulated upon cell treatment with oxLDLs. One of the 21, hsa-miR-122-5p, was also upregulated in MI cases (fold change = 4.85). Of the 28 CAD-related microRNAs tested, 11 were upregulated in MI cases -1 previously undescribed (hsa-miR-16-5p)-, and 1/11 was also associated with CAD incidence (adjusted hazard ratio = 0.55 (0.35-0.88)) and improved CAD risk reclassification, hsa-miR-143-3p. We identified 2 novel microRNAs modulated by oxLDLs in endothelial cells, 1 novel microRNA upregulated in AMI cases compared to controls, and one circulating microRNA that improved CAD risk classification.